Selected Grants
ATRXmutations,innate immune activation and therapeutic vunerabilityin malignant gliomas
ResearchCollaborator · Awarded by National Cancer Institute · 2022 - 2027Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027University Training Program in Biomolecular and Tissue Engineering
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1994 - 2027Basic Immunology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025Mechanisms and Clinical Impact of Myocardial Injury Following Traumatic Brain Injury
ResearchCo-Mentor · Awarded by National Institutes of Health · 2019 - 2025Viral Oncology Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1980 - 2025Experimental Therapy for Brain Tumors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2024Clinical Brain Tumor Development of a Cytomegalovirus-targeted Therapeutic with Vaccine pre-conditioning to Validate Novel Predictors of Vaccine Efficacy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2023Metabolic reprogramming to improve EGFRvIII CAR T cell persistence
ResearchSignificant Contributor · Awarded by University of North Carolina - Chapel Hill · 2023 - 2023Creating the next generation peptide vaccine directed at cytomegalovirus antigens in malignant brain
ResearchSignificant Contributor · Awarded by National Pediatric Cancer Foundation, Inc. · 2022 - 2023Human EGFRvIII-specific BiTE for the treatment of Glioblastoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2023Cabinet Radiation Therapy System for Small Animals
EquipmentMajor User · Awarded by North Carolina Biotechnology Center · 2022 - 2023Clinical Neuroimmunology of Vaccines in Brain Tumors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2022T32 UNC - Duke Immunotherapy Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by University of North Carolina - Chapel Hill · 2021 - 2022BATF3+ Dendritic Cells for the Treatment of Malignant Gliomas
ResearchCo-Mentor · Awarded by Department of Defense · 2020 - 2022Translational Research in Surgical Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2002 - 2022The Role of CD155 in Leptomeningeal Dissemination and Oncolytic Virus Susceptibility in the Medulloblastoma Microenvironment
ResearchMentor · Awarded by Department of Defense · 2018 - 2022Metabolic reprogramming to improve EGFRvIII CAR T cell persistence
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2022Image-Guided Radiation Therapy System for Small Animals
EquipmentMajor User · Awarded by National Institutes of Health · 2021 - 2022Medical Scientist Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1997 - 2022Is Low Tumor Mutational Burden Predictive of Response to Oncolytic Polio Virus Therapy in Recurrent Glioblastoma?
ResearchCollaborator · Awarded by National Institutes of Health · 2019 - 2022PBTF Institute Grant
ResearchPrincipal Investigator · Awarded by Pediatric Brain Tumor Foundation · 2015 - 2021CCL3 as a Developmental Therapeutic to Enhance Brain Tumor Therapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2021Improving CAR T cell immunotherapy for heterogeneous brain tumors
ResearchPrincipal Investigator · Awarded by University of Florida · 2019 - 2021Efficacy of dendritic cell vaccines targeting CMV antigens in glioblastoma
ResearchPrincipal Investigator · Awarded by University of Florida · 2017 - 2021Quantitative Staging and Therapeutic Response in IDH-1 Mutated Glioblastomas
ResearchCollaborator · Awarded by National Institutes of Health · 2017 - 2021EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2019Development of a Therapeutic for Brain Tumor Immunotherapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2019Systemically administrered EGRFvIII-targeted bispecific antibody as an immunotherapeutic for glioblastoma.
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2019Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2018Loglio Project
ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2016 - 2018Brain Tumor Targeting Using Tumor-Specific Neuroimmunology
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2018Targeting Translation Control in Malignant Glioma
ResearchCo Investigator · Awarded by National Institutes of Health · 2007 - 2018A clinically-relevant anti-CD27 agonist antibody as a vaccine adjuvant for brain tumor immunotherapy
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2017Enhancing dendritic cell migration to drive potent anti-tumor immune responses
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2017Use of YH24931 in combination with antigen-specific DC vaccines for antitumor efficacy
ResearchSignificant Contributor · Awarded by Yuhan Corporation · 2016 - 2017Pediatric Brain Tumor Consortium
Clinical TrialCollaborator · Awarded by St. Jude Children's Research Hospital · 2014 - 2017Research Training In Neuro-Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1998 - 2016HFTL event
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by BrainLAB, Inc. · 2016 - 2016Cancer Biology Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Cancer Institute · 1993 - 2016Clinical Oncology Research Career Development Program
ResearchMentor · Awarded by National Institutes of Health · 2009 - 2015Development of peptide vaccine for diffuse intrinsic pontine glioma
ResearchCo Investigator · Awarded by The Cure Starts Now · 2013 - 2014Convection Enhanced Delivery of Chemokines can increase T-Cell Chemotaxis to Brain Tumors in an Adoptive T cell Model
ResearchPrincipal Investigator · Awarded by American Brain Tumor Association · 2014 - 2014Targeting EGFRvIII in Brain Tumors with Bispecific Antibodies
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2014Modulation of the blood-tumor barrier through targeted suppression of claudin 5
ResearchMentor · Awarded by National Institutes of Health · 2011 - 2013RNA-based Immunotherapy Targeting Antigens Unique to Brain Tumor Stem Cells
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2008 - 2013Enterovirus Vectors with Respiratory Tropism for Cancer Immunotherapy
ResearchCo Investigator · Awarded by National Institutes of Health · 2009 - 2012Neuroimmunology of Vaccines in Adoptive T-cell Therapy for Brain Tumor
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2010 - 2012Pre-clinical Translation of Regulatory T-cell Inhibition in Brain Tumors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2010 - 2012Gene Targeted Therapy of Brain Tumors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2012Research Training In Neuro-Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2005 - 2010Effect on IL-2R Antibody on Regulatory T-cells in Patients with Malignant Gliomas
Clinical TrialPrincipal Investigator · Awarded by National Institutes of Health · 2008 - 2009Dendritic Cell Immunotherapy of Malignant Gliomas
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2008Intracerebral Infusion of Radiolabeled Specific Antibody
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2008Regional AGT Depletion of CNS and Leptomeningeal Tumors
ResearchCollaborator · Awarded by National Institutes of Health · 2002 - 2006GCRC CAP
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2000 - 2005External Relationships
- Annias Immunotherapeutics, Inc.
- Celldex
- Centuar Bio
- Cognos Therapeutics
- Immunomic Therapeutics
- Insera health
- Istari Oncology
- Medicenna Therapeutics
- Myeloid TX
- Shorla
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.